ORIGINAL RESEARCH
Accepted on 16 May 2025
Efficacy and safety of Eribulin-based Chemotherapy in HER2 negative advanced breast cancer patients: A Real-World Study
doi 10.3389/fonc.2025.1499701
- Frontiers in Oncology
- Breast Cancer
- Research Topics
- Challenges and Strategies in the Management of ER/PgR Low-Expression Breast Cancer: Exploring Fundamentals, Clinical Insights, and Treatment Approaches
Challenges and Strategies in the Management of ER/PgR Low-Expression Breast Cancer: Exploring Fundamentals, Clinical Insights, and Treatment Approaches
886
Total downloads
3,183
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Accepted on 13 May 2025
Nanoemulsion of Myricetin enhances its anti-tumor activity in nude mice of triple-negative breast cancer xenografts
doi 10.3389/fonc.2025.1563076
ORIGINAL RESEARCH
Published on 10 Mar 2025
Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution
doi 10.3389/fonc.2025.1496592
- 519 views
SYSTEMATIC REVIEW
Published on 28 Feb 2025
PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Asian patients with advanced triple-negative breast cancer: a phase III RCTs based meta-analysis
doi 10.3389/fonc.2025.1540538
- 1,018 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.